Table 3.
Multivariable logistic regression analysis to predict pN1 after RARP with ePLND in 318 patients with intermediate‐ and high‐risk PCa using predefined preoperative variables, including intraprostatic, intratumoral SUVmax, cT stage, PSA level, and bISUP grade. Effect sizes are presented as ORs with 95% CIs.
| 18F‐PSMA | 68Ga‐PSMA‐11 | |||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| log2 (Initial PSA value) | 0.76 (0.47–1.23) | 0.3 | 1.02 (0.74–1.41) | 0.9 |
| log2 (SUVmax prostate) | 1.79 (1.06–3.03) | 0.03 | 1.96 (1.27–3.01) | 0.002 |
| Prostate biopsy grade group according to ISUP * | ||||
| 1–2 | ||||
| 3 | 1.10 (0.26–4.68) | 0.9 | 1.07 (0.33–3.53) | 0.9 |
| ≥4 | 1.57 (0.43–5.77) | 0.5 | 1.63 (0.62–4.28) | 0.3 |
| cT stage | ||||
| cT1 | ||||
| cT2 (a,b,c) | 0.56 (0.20–1.59) | 0.3 | 1.74 (0.73–4.13) | 0.2 |
| cT3(a,b) | 0.71 (0.06–8.50) | 0.8 | 1.77 (0.59–5.35) | 0.3 |
ISUP 1 = Gleason score 3 + 3 = 6.
ISUP 2 = Gleason score 3 + 4 = 7.
ISUP 3 = Gleason score 4 + 3 = 7.
ISUP 4 = Gleason score 4 + 4 = 8/Gleason score 3 + 5 = 8/Gleason score 5 + 3 = 8.
ISUP 5 = Gleason score 4 + 5 = 9/Gleason score 5 + 4 = 9/Gleason score 5 + 5 = 10.
*
ISUP definition.